A4L Expands into JLABS @ Toronto

TORONTO, ON – Jan. 16, 2017 – Today, Analytics 4 Life (A4L), a machine intelligence company developing noninvasive, cost-effective medical devices, announced its expansion into JLABS @ Toronto, one of Johnson & Johnson Innovation’s life science incubators. As a resident in the space, A4L has access to a rich ecosystem of cardiovascular medical device development … Read more

OCE Success Story: Analytics 4 Life

Heart disease is the second leading cause of death in Canada and an estimated 1.3 million Canadians are currently living with it. Early detection is crucial to decreasing death rates, but current diagnostic techniques can be invasive and costly. Analytics 4 Life (A4L) has developed an analytics platform with the potential to disrupt the health-care space … Read more

IBM launches Toronto startup hub, enrolls first participant

IBM and the Ontario Centres of Excellence launched a startup hub in Toronto this week, enrolling e-health player Analytics 4 Life (A4L) as its first participant. The IBM Innovation Space is the first program to launch under IBM’s $54 million Innovation Incubator Project, according to a statement. The company put up $24.75 million for the … Read more

A4L Announces IBM Innovation Space Participation

TORONTO, ON – Sep. 22, 2016 – Yesterday at a gathering of IBM executives and Ontario government officials, Analytics 4 Life (A4L), a Toronto-based eHealth company, announced its participation in the new and first IBM Innovation Space. Earlier this year, the Ontario government partnering with the Ontario Centres of Excellence (OCE) and IBM committed $54 … Read more

A4L Announces Research Award from SOSCIP and OCE

TORONTO, ON – Sep. 14, 2016 – Today, Analytics 4 Life (A4L), a Toronto-based eHealth company, announced its second project award by Southern Ontario Smart Computing Innovation Platform (SOSCIP) and Ontario Centres of Excellence (OCE). The focus of the new project is to create a proprietary machine learning computational algorithm that can analyze physiologic signals … Read more

Analytics 4 Life Takes The Stress Out Of Coronary Artery Disease Tests

TORONTO, Jun. 8, 2016 /TechPORTFOLIO/ — Data collected and crunched in the cloud aims to replace test that involves radioactive dye injections and running on a treadmill. For a disease recognized as the most common global cause of death – 8.14 million worldwide in 2013 – coronary artery disease is extremely laborious to diagnose. A Canadian … Read more

Unheralded medtech success

An unheralded story of medtech success – How Sapheon went from an idea on the back of a napkin to a $240 million exit to Covidien – MassDevice Welcome to the Medsider interview series, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder of Medsider and … Read more

A4L Appoints William E. Sanders, Jr. MD MBA Chief Medical Officer And Nick Leb Chief Financial Officer

TORONTO, Jan. 12, 2016 /PRNewswire/ — A4L (Analytics 4 Life), a medical information technology company that uses advanced signal processing techniques for the purposes of detecting and assessing disease, today announced the appointment of William E. (Gene) Sanders, Jr. MD MBA as Chief Medical Officer and Nick Leb as Chief Financial Officer. “Gene and Nick are … Read more

Stealth machine learning startup raises $10M to develop a heart disease detection algorithm

Stealthy machine learning player A4L announced that it has raised CA$10 million ($7.1 million) to develop and test its algorithm for heart disease. The Toronto-based company says that its proprietary variable extraction algorithm has analyzed and manipulated 2 billion data points in laboratory research, which was supported by the Southern Ontario Smart Computing Innovations Platform … Read more

A4L Raises C$10m Series A Financing And Appoints Don Crawford President And Chief Executive Officer

TORONTO, Jan. 6, 2016 /PRNewswire/ — A4L (Analytics 4 Life), a medical information technology company that uses advanced signal processing techniques for the purposes of detecting and assessing disease, today announced it has raised C$10 million in Series A financing by private accredited investors in an oversubscribed round. Additionally, the company announced the appointment of Don … Read more